Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza - Concepedia

Concepedia

Publication | Open Access

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

DOI Full Paper Access

487

Citations

41

References

2020

Year

Timothy R. Abbott, Girija Dhamdhere, Yanxia Liu, Xueqiu Lin, Laine Goudy, Leiping Zeng, Augustine Chemparathy, Nicholas S. Heaton, Robert J. Debs, Tara Pande,

Combat Sars-cov-2ImmunologyVirologyAntiviral StrategyGene EditingGenome EditingOff-target EffectMedicineCrisprCovid-19

References

	Year	Citations

Page 1

Page 1